Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Clearmind Medicine Inc. CMND

Set alert

Price alert · CMND

All alert types
6.14 USD -0.36 -5.52%

At close · Nov 2

6.03 -0.11 -1.79%

After hours · Nov 2, 4:00 PM ET

Bid
6.04 × 2
Ask
6.23 × 1
6.02 Day range 6.14
5.25 52-week range 2,688.00
YTD
-95.76%
1 year
-99.76%
Open
6.02
Prev close
6.50
Mkt cap
3.12M
Vol
1.83K
Avg vol
58.53K
EPS
-461.20
P/E
0.00
Div yield
0.00%
More statistics
Low
6.02
High
6.14
Forward P/E
0.00
Beta
-1.51
Short ratio
1.88
Inst. own
16.02%
Dividend
0.00
Ex-div date
50-d avg
1.39
200-d avg
1.33
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 5, 2026Split: 1 for 8
Signals (9)
NameDateAgo
MACD: Buy SignalSep 28, 20261 month ago
MACD: Sell SignalSep 4, 20261 month ago
RSI: OversoldSep 4, 20261 month ago
SMA: BearishSep 3, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 13, 20262 months ago

Financial health

Altman Z-Score

-2.92 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -105×
FY 2017: -42436×FY 2018: -1267×FY 2019: -2761×FY 2020: -1857×FY 2021: -185×FY 2022: -105×FY 2023: -8.6×FY 2024: -82.0×FY 2025: -105×
FY 2017 5y median -105× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 339×
FY 2017: 5648×FY 2018: 1378×FY 2019: 2825×FY 2020: 1141×FY 2021: 175×FY 2022: -696×FY 2023: 75.4×FY 2024: 99.6×FY 2025: 339×
FY 2017 5y median 99.6× FY 2025
P/FCF -85.4×
FY 2017: -10122×FY 2018: -1392×FY 2019: -5177×FY 2020: -2076×FY 2021: -301×FY 2022: -206×FY 2023: -11.8×FY 2024: -63.7×FY 2025: -85.4×
FY 2017 5y median -85.4× FY 2025
EV/EBITDA -108×
FY 2017: -42693×FY 2018: -1267×FY 2019: -2756×FY 2020: -1857×FY 2021: -184×FY 2022: -107×FY 2023: -8.0×FY 2024: -88.1×FY 2025: -108×
FY 2017 5y median -107× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -1.2%
FY 2017: -0.0%FY 2018: -0.1%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.3%FY 2022: -0.5%FY 2023: -8.5%FY 2024: -1.6%FY 2025: -1.2%
FY 2017 5y median -1.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -323.4%
FY 2017: -13.2%FY 2018: -108.7%FY 2019: -102.5%FY 2020: -61.4%FY 2021: -94.4%FY 2022: 661.4%FY 2023: -875.4%FY 2024: -121.5%FY 2025: -323.4%
FY 2017 5y median -121.5% FY 2025
ROIC -190.7%
FY 2017: -13.2%FY 2018: -142.2%FY 2019: -102.5%FY 2020: -61.4%FY 2021: -93.3%FY 2022: 621.2%FY 2023: -640.1%FY 2024: -130.6%FY 2025: -190.7%
FY 2017 5y median -130.6% FY 2025
ROA -63.4%
FY 2017: -6.5%FY 2018: -105.3%FY 2019: -76.9%FY 2020: -59.8%FY 2021: -87.8%FY 2022: -885.1%FY 2023: -144.6%FY 2024: -52.0%FY 2025: -63.4%
FY 2017 5y median -87.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 1.4%
FY 2017: 0.0%FY 2018: -3869.9%FY 2019: 59.8%FY 2020: -121.0%FY 2021: -1470.1%FY 2022: -149.1%FY 2023: 30.1%FY 2024: 8.7%FY 2025: 1.4%
FY 2017 FY 2025
EPS (diluted) 55.3%
FY 2017: 0.0%FY 2018: -3318.6%FY 2019: 54.1%FY 2020: -50.4%FY 2021: -832.0%FY 2022: -93.7%FY 2023: 81.4%FY 2024: 96.0%FY 2025: 55.3%
FY 2017 FY 2025
Free Cash Flow 30.0%
FY 2017: 0.0%FY 2018: -555.1%FY 2019: 69.3%FY 2020: -271.6%FY 2021: -990.5%FY 2022: -125.4%FY 2023: -24.5%FY 2024: -7.3%FY 2025: 30.0%
FY 2017 FY 2025

Financial Health

Current Ratio 1.2×
FY 2017: 1.7×FY 2018: 10.7×FY 2019: 0.1×FY 2020: 24.9×FY 2021: 13.8×FY 2022: 0.2×FY 2023: 1.2×FY 2024: 1.7×FY 2025: 1.2×
FY 2017 5y median 1.2× FY 2025
Quick Ratio 1.2×
FY 2017: 1.7×FY 2018: 10.7×FY 2019: 0.1×FY 2020: 24.9×FY 2021: 13.8×FY 2022: 0.2×FY 2023: 1.2×FY 2024: 1.7×FY 2025: 1.2×
FY 2017 5y median 1.2× FY 2025
Debt / Equity 1.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.5×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2017: 12.2×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 1.1×FY 2021: 1.0×FY 2022: 0.0×FY 2023: 0.6×FY 2024: 1.9×FY 2025: 0.6×
FY 2017 5y median 0.6× FY 2025
Interest Coverage -290×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -434×FY 2023: 0.0×FY 2024: -159×FY 2025: -290×
FY 2017 5y median -159× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-10-31